Jul 2024 $130 M Private placement after listing $50 to $250 million 22
Selecta Biosciences Inc.: Private sale, Jul 2024 × Investors in this round 22 investors had bought by the notice of Jul 17, 2024: 22 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 20 investors are named for Selecta Biosciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $130 M of $130 M offered
Smallest investment taken no minimum stated
What was sold equity, other: common stock and convertible preferred stock convertible into common stock Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $4,969,980
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Blaine Davis · Executive Officer Carsten Brunn · Executive Officer, Director Chris A. Jewell · Executive Officer Emily A. English · Executive Officer Metin A. Kurtoglu · Executive Officer Milos A. Miljkovic · Executive Officer Carrie S. Cox · Director Kemal C. Malik · Director Michael C. Singer · Director Murat C. Kalayoglu · Director Nishan C. de Silva · Director Patrick A. Zenner · Director Timothy A. Springer · Director Timothy C. Barabe · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Blaine Davis, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 17, 2024. Read the notice at the SEC .
equity SEC Jul 2020 $25 M Private placement after listing $10 to $50 million 1
Selecta Biosciences Inc.: Private sale, Jul 2020 × Investors in this round 1 investor had bought by the notice of Aug 18, 2020: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 20 investors are named for Selecta Biosciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $25 M of $25 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Bradford D. Dahms · Executive Officer Carsten Brunn · Executive Officer, Director Elona Kei Kogan · Executive Officer Lloyd D. Johnston · Executive Officer Stephen Kei Smolinksi · Executive Officer Takashi Kei Kishimoto · Executive Officer Aymeric Kei Sallin · Director Carrie Kei Cox · Director Goran Kei Ando · Director Patrick Kei Zenner · Director Scott Kei Myers · Director Timothy Kei Barabe · Director Timothy Kei Springer · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Bradford D. Dahms, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 18, 2020. Read the notice at the SEC .
equity SEC Dec 2019 $70 M Private placement after listing $50 to $250 million 26
Selecta Biosciences Inc.: Private sale, Dec 2019 × Investors in this round 26 investors had bought by the notice of Jan 2, 2020: 26 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 20 investors are named for Selecta Biosciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $70 M of $70 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $4,200,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Alison Kei Schecter · Executive Officer Bradford Dahms · Executive Officer Carsten Brunn · Executive Officer, Director Elona Kei Kogan · Executive Officer Lloyd Johnston · Executive Officer Stephen Kei Smolinski · Executive Officer Takashi Kei Kishimoto · Executive Officer Amir Dunseth Nashat · Director Aymeric Dunseth Sallin · Director Carrie Kei Cox · Director Patrick Dunseth Zenner · Director Scott Dunseth Myers · Director Timothy Dunseth Springer · Director Timothy Kei Barabe · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Cantor Fitzgerald LP (CRD 134) · New York, New York Sold in CA, FL, MA, MN, NY, UT, WA Janney Montgomery Scott LLC (CRD 463) · Philadelphia, Pennsylvania Sold in CA, FL, MA, MN, NY, UT, WA Canaccord Genuity LLC (CRD 1020) · New York, New York Sold in CA, FL, MA, MN, NY, UT, WA Needham & Company (CRD 16360) · New York, New York Sold in CA, FL, MA, MN, NY, UT, WA Signed by Matthew W. Bartholomae, Associate General Counsel. Source: SEC Form D, newest notice filed Jan 2, 2020. Read the notice at the SEC .
equity, options SEC Aug 2019 $6 M Private placement after listing $2 to $10 million 10
Selecta Biosciences Inc.: Private sale, Aug 2019 × Investors in this round 10 investors had bought by the notice of Sep 4, 2019: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 20 investors are named for Selecta Biosciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Alison Kei Schecter · Executive Officer Carsten Brunn · Executive Officer, Director Elona Kei Kogan · Executive Officer Lloyd Johnston · Executive Officer Stephen Kei Smolinski · Executive Officer Takashi Kei Kishimoto · Executive Officer Amir Kei Nashat · Director Aymeric Kei Sallin · Director Omid Kei Farokhzad · Director Patrick Kei Zenner · Director Scott D. Myers · Director Timothy Kei Barabe · Director Timothy Kei Springer · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Elona Kogan, General Counsel and Secretary. Source: SEC Form D, newest notice filed Sep 4, 2019. Read the notice at the SEC .
equity SEC Jun 2017 $50 M Private placement after listing $50 to $250 million 11
Selecta Biosciences Inc.: Private sale, Jun 2017 × Investors in this round 11 investors had bought by the notice of Jul 11, 2017: 11 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 20 investors are named for Selecta Biosciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $50 M of $50 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $2,640,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Delaware People named in the notice David Kei Abraham · Executive Officer David Kei Siewers · Executive Officer Earl Kei Sands · Executive Officer Lloyd Johnston · Executive Officer Peter Kei Keller · Executive Officer Takashi Kei Kishimoto · Executive Officer Werner Cautreels · Executive Officer, Director Amir Barton Nashat · Director Aymeric Barton Sallin · Director Omid C. Farokhzad · Director Patrick Barton Zenner · Director Peter Barton Hutt · Director Timothy Barton Springer · Director Timothy C. Barabe · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Stifel, Nicolaus & Company Incorporated (CRD 793) · San Francisco, California Sold in CA, CT, FL, MA, NY Signed by Werner Cautreels, President and CEO. Source: SEC Form D, newest notice filed Jul 11, 2017. Read the notice at the SEC .
equity, options SEC Dec 2016 $5 M No. 8 $2 to $10 million 1
Selecta Biosciences Inc.: Raise no. 8, Dec 2016 × Investors in this round 1 investor had bought by the notice of Dec 14, 2016: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 20 investors are named for Selecta Biosciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Kei Abraham · Executive Officer David Kei Siewers · Executive Officer Earl Kei Sands · Executive Officer Lloyd Johnston · Executive Officer Peter Kei Keller · Executive Officer Takashi Kei Kishimoto · Executive Officer Werner Cautreels · Executive Officer, Director Amir M. Nashat · Director Aymeric M. Sallin · Director Carl C. Gordon · Director Edwin M. Kania, Jr. · Director Omid C. Farokhzad · Director Peter Barton Hutt · Director Timothy C. Barabe · Director Timothy M. Springer · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Werner Cautreels, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 14, 2016. Read the notice at the SEC .
equity SEC Aug 2015 $37 M No. 7 $10 to $50 million 19
Selecta Biosciences Inc.: Raise no. 7, Aug 2015 × Investors in this round 19 investors had bought by the notice of Sep 10, 2015: 19 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 20 investors are named for Selecta Biosciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $37 M of $41 M offered; $3 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David M. Abraham · Executive Officer David M. Siewers · Executive Officer Earl Kei Sands · Executive Officer Lloyd M. Johnston · Executive Officer Peter Kei Keller · Executive Officer Takashi Kei Kishimoto · Executive Officer Werner Cautreels · Executive Officer, Director Amir M. Nashat · Director Aymeric M. Sallin · Director Carl Gordon · Director Edwin M. Kania, Jr. · Director George M. Siber · Director Leysan M. Shaydullina · Director Omid Farokhzad · Director Peter Barton Hutt · Director Robert M. Langer · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David Abraham, General Counsel. Source: SEC Form D, newest notice filed Sep 10, 2015. Read the notice at the SEC .
equity, options SEC Apr 2015 $6 M No. 6 $2 to $10 million 12
Selecta Biosciences Inc.: Raise no. 6, Apr 2015 × Investors in this round 12 investors had bought by the notice of Apr 23, 2015: 12 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 20 investors are named for Selecta Biosciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $6 M of $8 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David M. Abraham · Executive Officer David M. Siewers · Executive Officer Lloyd M. Johnston · Executive Officer Peter Kei Keller · Executive Officer Takashi Kei Kishimoto · Executive Officer Werner Cautreels · Executive Officer, Director Amir M. Nashat · Director Aymeric M. Sallin · Director Carl Gordon · Director Edwin M. Kania, Jr. · Director George M. Siber · Director Omid Farokhzad · Director Peter Barton Hutt · Director Robert M. Langer · Director Yuriy M. Udaltsov · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David Abraham, General Counsel. Source: SEC Form D, newest notice filed Apr 23, 2015. Read the notice at the SEC .
debt, options SEC Aug 2014 $4 M No. 5 $2 to $10 million 11
Selecta Biosciences Inc.: Raise no. 5, Aug 2014 × Investors in this round 11 investors had bought by the notice of Aug 28, 2014: 11 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 20 investors are named for Selecta Biosciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken $100,000
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Massachusetts People named in the notice David M. Abraham · Executive Officer David M. Siewers · Executive Officer Werner Cautreels · Executive Officer, Director Amir M. Nashat · Director Aymeric M. Sallin · Director Carl Gordon · Director Edwin M. Kania, Jr. · Director George M. Siber · Director Omid Farokhzad · Director Peter Barton Hutt · Director Robert M. Langer · Director Yuriy M. Udaltsov · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David Siewers, Treasurer. Source: SEC Form D, newest notice filed Aug 28, 2014. Read the notice at the SEC .
equity SEC Jul 2014 $6 M No. 4 $2 to $10 million 2
Selecta Biosciences Inc.: Raise no. 4, Jul 2014 × Investors in this round 2 investors had bought by the notice of Jul 15, 2014: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 20 investors are named for Selecta Biosciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken $3,000,000
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Massachusetts People named in the notice David M. Abraham · Executive Officer David M. Siewers · Executive Officer Werner Cautreels · Executive Officer, Director Amir M. Nashat · Director Aymeric M. Sallin · Director Carl Gordon · Director Edwin M. Kania, Jr. · Director George M. Siber · Director Omid Farokhzad · Director Peter Barton Hutt · Director Robert M. Langer · Director Yuriy M. Udaltsov · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David Siewers, Treasurer. Source: SEC Form D, newest notice filed Jul 15, 2014. Read the notice at the SEC .
equity SEC Apr 2014 $5 M No. 3 $2 to $10 million 11
Selecta Biosciences Inc.: Raise no. 3, Apr 2014 × Investors in this round 11 investors had bought by the notice of Apr 9, 2014: 11 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 20 investors are named for Selecta Biosciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $5 M of $10 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Massachusetts People named in the notice David M. Abraham · Executive Officer David M. Siewers · Executive Officer Werner Cautreels · Executive Officer, Director Amir M. Nashat · Director Aymeric M. Sallin · Director Carl Gordon · Director Edwin M. Kania, Jr. · Director George M. Siber · Director Omid Farokhzad · Director Peter Barton Hutt · Director Robert M. Langer · Director Yuriy M. Udaltsov · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by David Siewers, Treasurer. Source: SEC Form D, newest notice filed Apr 9, 2014. Read the notice at the SEC .
equity SEC Nov 2011 $22 M No. 2 $10 to $50 million 16
Selecta Biosciences Inc.: Raise no. 2, Nov 2011 × Investors in this round 16 investors had bought by the notice of Nov 17, 2011: 16 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 20 investors are named for Selecta Biosciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $22 M of $22 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Massachusetts People named in the notice David Barton Siewers · Executive Officer Werner Cautreels · Executive Officer, Director Amir Barton Nashat · Director Aymeric Barton Sallin · Director Carl Gordon · Director Cole Douglas · Director George Barton Siber · Director Omid Farokhzad · Director Peter Barton Hutt · Director Robert Barton Langer · Director Yuriy Barton Udaltsov · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “None other than salaries and bonuses in the ordinary course of business.”Signed by David Siewers, Vice President of Finance. Source: SEC Form D and 1 amendment, newest notice filed Nov 17, 2011. Read the notice at the SEC .
equity SEC Mar 2010 $15 M No. 1 $10 to $50 million 14
Selecta Biosciences Inc.: Raise no. 1, Mar 2010 × Investors in this round 14 investors had bought by the notice of Apr 6, 2010: 14 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 20 investors are named for Selecta Biosciences Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $15 M of $15 M offered
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Massachusetts People named in the notice Robert L. Bratzler · Executive Officer, Director Amir L. Nashat · Director Aymeric L. Sallin · Director Carl L. Gordon · Director Douglas L. Cole · Director George Barton Siber · Director Omid L. Farokhzad · Director Peter Barton Hutt · Director Robert S. Langer, Jr. · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “None other than salaries and bonuses in the ordinary course of business.”Signed by Robert L. Bratzler, Executive Chairman. Source: SEC Form D, newest notice filed Apr 6, 2010. Read the notice at the SEC .
equity SEC